We talk about adherence all the time: medication, diary cards, appointments. We know it is crucial, yet there have been many times when I have asked myself, do people really get it? Or are we just expecting them to follow instructions blindly? Honestly, I think we can do better.
We often tell you what to do, but not always why it’s important. We might explain the science (which can be confusing or seem less relevant to your needs), but do we really connect with you on a personal level? Do we explain how your participation impacts not just your health, but the future of treatment for everyone? I’d argue we often fall short.
For me this is the fundamental problem with adherence. When you understand the why, you are far more likely to stick with the program, whether it is taking medication, filling out those (sometimes tedious) diary cards, or attending appointments on time. It is not about blind obedience; it is about informed participation. It is about you becoming a true partner in your care.
I have written this post spurred on by a post from my colleague Philip Morisky, MBA, about World Adherence Day which is just around the corner (27 March). Well done to the World Heart Federation for bringing this vital topic into focus! What can we, as an industry, do to improve patient education and, ultimately, improve patient commitment?
Always one for looking at the practical, here is my take. We have great tools at our disposal. We have tech from InHandPlus to help monitor medication usage, AI voice agents like Delfa (Tom Farrand) to support patients and sites, and engagement tools like the one offered by Jonathan Moshinsky and his team at Stitch to help keep people on track. Let’s not forget the power of personalization: companies like BIONABU are doing some really interesting work in this space. Of course, when it comes to medication adherence, well, there is adherence itself, with the gold standard hashtag #MMAS.
These tools are great, but they only work if we use them thoughtfully. It is not just about having the tools and tech; it is about weaving them into your experience so they build trust, foster understanding, and help you take control of your health.
So, my ask as we approach World Adherence Day: Let’s move beyond simply telling you to adhere and start truly engaging you in the process of clinical trial adherence. Let’s make the why clear and give you the support you need to succeed. When you understand the why, you become partners with us in our collective drug discovery and usage journeys and for me that is something worth sticking with.
Staying Committed Through Clinical Trials
Adhering to clinical trial protocols improves the outcome of your treatment. Trials are designed with safety and efficacy in mind, and following the schedule for medications, tests, and visits ensures that your treatment has the best chance of working as intended. Skipping doses or missing appointments affects your results and leads to uncertain conclusions about the effectiveness of a therapy.
Consistency also reduces risks. Clinical trials are structured to monitor your responses carefully and identify potential side effects early. Regular follow-ups allow your medical team to make adjustments if necessary. For people with serious or chronic conditions, staying engaged can mean receiving better care, more frequent monitoring, and earlier interventions.
Beyond personal benefits, your commitment impacts future treatments. Every clinical trial contributes to the understanding of disease and treatment options. Reliable participation ensures that data is valid and applicable to wider populations, improving care for future patients with similar conditions.
Clinical trials allow you to access new treatments before they become widely available. Many clinical trials test therapies that could become the standard of care in the future, giving you early access to potentially life-changing options. This can be particularly important for conditions where current treatments offer limited relief or have severe side effects.
The Role of Clinical Trial Adherence in Data Reliability
Accurate data drives medical progress. When you follow the prescribed treatment plan, the study results better reflect how a therapy performs under controlled conditions. This strengthens the evidence base, making it more likely that beneficial treatments will receive approval and reach the people who need them.
Adherence gaps create challenges. If a significant number of participants deviate from the protocol, the trial will not provide clear answers about a treatment’s safety or effectiveness. This can slow down approvals or lead to inconclusive results. Researchers depend on you for findings that translate into real-world clinical use.
Long-term patient commitment is especially important in trials for chronic illnesses or progressive diseases. Understanding how a treatment works over months or years requires your consistent participation. Without it, the long-term benefits and risks of a therapy remain uncertain, limiting its potential impact.
Strong clinical trial adherence helps regulatory bodies accurately evaluate the reliability of a new treatment. Inconsistent participation may result in a failed trial, not because the therapy is ineffective, but because data gaps prevent a proper analysis. This means that promising treatments could be delayed or even abandoned, denying future patients access to potentially effective solutions.
How Patient Commitment Improves Well-Being
Clinical trial participation often gives you access to advanced medical care. You can receive close monitoring, regular check-ups, and specialist consultations that may not always be available in standard care settings. This extra attention can improve your well-being and ensure that your concerns are addressed quickly.
Support systems are also built into trials. Many studies offer patient advocacy groups, counseling services, and dedicated coordinators who help you navigate the process. These resources make it easier for you to stay engaged and offer guidance on managing treatment schedules, side effects, and personal concerns.
Commitment also fosters a sense of contribution. You can find reassurance in knowing that your participation is advancing medicine and potentially benefiting others with the same condition. Patient commitment goes beyond the individual benefit to you: it shapes future treatments and improves medical knowledge.
Overcoming Barriers to Participation
We understand that staying engaged in a clinical trial is not always easy. You may face logistical challenges, such as travel time, frequent appointments, or managing side effects. Researchers and trial sponsors are creating solutions that make participation more doable. The best time to weigh those demands is before you join, while you can still ask whether the schedule fits your life.
Decentralized trials allow for remote monitoring and at-home sample collection to reduce your travel burden. Telemedicine follow-ups and digital tracking tools help you stay connected without needing to visit a hospital or clinic as frequently.
Financial support is another factor. Many clinical trials offer travel expense reimbursements or provide access to medications at no cost. These benefits make participation more feasible for a wider range of people.
Communication with the trial team is essential. You are more likely to remain engaged when you ask questions, voice concerns, and seek support when needed. Trial coordinators and healthcare providers can help address difficulties and find solutions that keep you active in the study.
You also benefit from being part of a supportive research community. Many trials include peer networks where you can connect with, share experiences, and encourage each other. This sense of shared commitment can make staying in a study easier and more rewarding.
Healthcare providers play an essential role in supporting participation. When doctors and trial coordinators build strong relationships with you, trust is established, making it easier for you to stay engaged. Open discussions about expectations, potential challenges, and available support systems improve retention and make you feel valued throughout the study. If you are weighing a study now, the medifit™ + readifit™ self-reflection tools help you ask two questions before you commit: Is this trial right for my health? Is this trial right for my life? Reflect on whether a trial could fit your life.
About the author
Keith Berelowitz has spent more than twenty years watching clinical trials work on paper and struggle in real life. He has helped run studies, advises sponsors and CROs on how they engage with people, and chairs a UK research ethics committee, where consent forms and participant information sheets cross his desk every month. That vantage point led to one conclusion: most trial problems are not failures of science. They are failures of understanding at the moment a person decides.
He founded trialport, a clinical trial navigation and decision-support platform, to help people weigh a trial in the context of real life rather than on paper alone. Its medifit™ + readifit™ self-reflection tools ask two questions: Is this trial right for my health? Is this trial right for my life? Understanding comes first. Decisions follow.